Though not the guideline-recommended route for treatment, select breast cancer patients could benefit greatly from MRI screenings designed to identify brain metastases, according to a research letter penned this month by Dana-Farber/Brigham and Women’s Cancer Center experts and published in JAMA Oncology.

A team of scientists found therapeutic treatment using radiopharmaceutical I-131 mIBG can effectively mitigate symptoms of certain neuroendocrine tumors and resulted in improved prognosis for patients with symptomatic progression, radiographic response or stability and biochemical response.

A new discovery involving diamonds may significantly cut costs related to medical imaging and drug-discovery devices, according to a team of researchers led by the U.S. Department of Energy and the University of California, Berkeley. 

Microsoft will collaborate with Case Western Reserve University in Cleveland to improve the accuracy of MRI results in less time through an approach called "magnetic resonance fingerprinting."

A team of German researchers used PET/CT and modeling practices to create a new method to pattern and predict tumor response in radioligand therapy (RLT), which authors say is the first attempt to do so.

Conventional MRI has a new use in the clinical setting, Canadian researchers wrote in Radiology this month: measuring lung ventilation abnormalities in free-breathing patients.

New ultrasound guidelines can accurately identify pediatric patients who should undergo biopsy for thyroid cancer, according to recent research presented at the Society for Pediatric Radiology’s annual meeting in Nashville, Tennessee. 

The "disease screening pill," developed by researchers from the University of Michigan, lit up malignant tumors in mice when exposed to near-infrared light—all without the use of radiation, according to a study published in Molecular Pharmaceutics.